Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Flemming_Ørnskov
|
| gptkbp:focus |
Aesthetic dermatology
Consumer care Medical dermatology |
| gptkbp:founded |
1981
|
| gptkbp:hasResearchCenter |
gptkb:France
gptkb:Sweden gptkb:United_States |
| gptkbp:headquartersLocation |
gptkb:Lausanne,_Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Galderma
|
| gptkbp:industry |
Dermatology
|
| gptkbp:IPODate |
2024
|
| gptkbp:market |
Worldwide
|
| gptkbp:notableAcquisition |
gptkb:Q-Med
|
| gptkbp:notableEvent |
Nestlé acquired full ownership in 2014
Sold to EQT, Abu Dhabi Investment Authority, and PSP Investments in 2019 |
| gptkbp:numberOfEmployees |
~5,000
|
| gptkbp:parentCompany |
gptkb:L'Oréal
gptkb:Nestlé Independent (as of 2019) |
| gptkbp:products |
gptkb:Cetaphil
gptkb:Aklief gptkb:Differin gptkb:Epiduo gptkb:Mirvaso gptkb:Oracea gptkb:Restylane gptkb:Sculptra |
| gptkbp:stockExchange |
gptkb:SIX_Swiss_Exchange
|
| gptkbp:website |
https://www.galderma.com/
|
| gptkbp:bfsParent |
gptkb:Cetaphil
gptkb:EQT_AB |
| gptkbp:bfsLayer |
6
|